Morphologic, Distributional, Volumetric, and Intensity Characterization of Periventricular Hyperintensities

REFERENCES

1. 1.↵
   1. Wen W,
   2. Sachdev P

   . The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 2004;22:144–54

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Fazekas F,
   2. Chawluk JB,
   3. Alavi A,
   4. et al

   . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Krishnan KR,
   2. Boyko OB,
   3. McDonald WM,
   4. et al

   . Magnetic-resonance morphometry: Image-analysis methodology development for affective disorder. Depression 1993;1:159–71
4. 4.↵
   1. Brickman AM,
   2. Sneed JR,
   3. Provenzano FA,
   4. et al

   . Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res 2011;193:101–06

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Payne ME,
   2. Fetzer DL,
   3. MacFall JR,
   4. et al

   . Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res 2002;115:63–77

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kim KW,
   2. MacFall JR,
   3. Payne ME

   . Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008;64:273–80

   CrossRefPubMed
7. 7.↵
   1. Ramirez J,
   2. Gibson E,
   3. Quddus A,
   4. et al

   . Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage 2011;54:963–73

   CrossRefPubMed
8. 8.↵
   1. Sachdev P,
   2. Chen X,
   3. Wen W

   . White matter hyperintensities in mid-adult life. Curr Opin Psychiatry 2008;21:268–74

   CrossRefPubMedWeb of Science
9. 9.↵
   1. van der Lijn F,
   2. Verhaaren BF,
   3. Ikram MA,
   4. et al

   . Automated measurement of local white matter lesion volume. Neuroimage 2012;59:3901–08

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Ge Y,
    2. Grossman RI,
    3. Babb JS,
    4. et al

    . Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2003;24:1935–40

    Abstract/FREE Full Text
11. 11.↵
    1. Appelman AP,
    2. Vincken KL,
    3. van der Graaf Y,
    4. et al

    . White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study. Cerebrovasc Dis 2010;29:28–35

    CrossRefPubMed
12. 12.↵
    1. DeCarli C,
    2. Fletcher E,
    3. Ramey V,
    4. et al

    . Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005;36:50–55

    Abstract/FREE Full Text
13. 13.↵
    1. Deary IJ,
    2. Gow AJ,
    3. Taylor MD,
    4. et al

    . The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr 2007;7:28

    CrossRefPubMed
14. 14.↵
    1. Wardlaw JM,
    2. Bastin ME,
    3. Valdés Hernández MC,
    4. et al

    . Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol. Int J Stroke 2011;6:547–59

    CrossRefPubMedWeb of Science
15. 15.↵
    1. van Straaten EC,
    2. Fazekas F,
    3. Rostrup E,
    4. et al

    . Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006;37:836–40

    Abstract/FREE Full Text
16. 16.↵
    1. Enzinger C,
    2. Fazekas F,
    3. Ropele S,
    4. et al

    . Progression of cerebral white matter lesions: clinical and radiological considerations. J Neurol Sci 2007;257:5–10

    CrossRefPubMed
17. 17.↵
    1. Conijn MM,
    2. Kloppenborg RP,
    3. Algra A,
    4. et al

    . Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study. Stroke 2011;42:3105–09

    Abstract/FREE Full Text
18. 18.↵
    1. Moore GR,
    2. Laule C,
    3. Mackay A,
    4. et al

    . Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss. J Neurol 2008;255:1802–12, discussion 1812

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Filippi M,
    2. Rocca MA

    . Dirty-appearing white matter: a disregarded entity in multiple sclerosis. AJNR Am J Neuroradiol 2010;31:90–91

    CrossRef
20. 20.↵
    1. Valdés Hernández MC,
    2. Morris Z,
    3. Dickie DA,
    4. et al

    . Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology 2013;40:13–22

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Hernández MC,
    2. Ferguson KJ,
    3. Chappell FM,
    4. et al

    . New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol 2010;20:1684–91

    CrossRefPubMed
22. 22.↵
    1. Bakshi R,
    2. Caruthers SD,
    3. Janardhan V,
    4. et al

    . Intraventricular CSF pulsation artifact on fast fluid-attenuated inversion-recovery MR images: analysis of 100 consecutive normal studies. AJNR Am J Neuroradiol 2000;21:503–08

    Abstract/FREE Full Text
23. 23.↵
    1. Mayer PL,
    2. Kier EL

    . The controversy of the periventricular white matter circulation: a review of the anatomic literature. AJNR Am J Neuroradiol 1991;12:223–28

    FREE Full Text
24. 24.↵
    1. Jongen C,
    2. van der Grond J,
    3. Anbeek P,
    4. et al

    . Construction of periventricular white matter hyperintensity maps by spatial normalization of the lateral ventricles. Hum Brain Mapp 2009;30:2056–62

    CrossRefPubMed
25. 25.↵
    1. Murray AD,
    2. Staff RT,
    3. Shenkin SD,
    4. et al

    . Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005;237:251–57

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Godin O,
    2. Tzourio C,
    3. Maillard P,
    4. et al

    . Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011;123:266–73

    Abstract/FREE Full Text
27. 27.↵
    1. de Leeuw FE,
    2. de Groot JC,
    3. Oudkerk M,
    4. et al

    . Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765–72

    Abstract/FREE Full Text
28. 28.↵
    1. Pantoni L,
    2. Garcia JH

    . Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–59

    Abstract/FREE Full Text
29. 29.↵
    1. De Groot CJ,
    2. Bergers E,
    3. Kamphorst W,
    4. et al

    . Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p) reactive lesions. Brain 2001;124:1635–45

    Abstract/FREE Full Text
30. 30.↵
    1. Admiraal-Behloul F,
    2. van den Heuvel DM,
    3. Olofsen H,
    4. et al

    . Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 2005;28:607–17

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Klöppel S,
    2. Abdulkadir A,
    3. Hadjidemetriou S,
    4. et al

    . A comparison of different automated methods for the detection of white matter lesions in MRI data. Neuroimage 2011;57:416–22

    CrossRefPubMedWeb of Science
32. 32.↵
    1. McAleese KE,
    2. Firbank M,
    3. Hunter D,
    4. et al

    . Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathol Appl Neurobiol 2013;39:485–97

    CrossRefPubMed
33. 33.↵
    1. Scully M,
    2. Anderson B,
    3. Lane T,
    4. et al

    . An automated method for segmenting white matter lesions through multi-level morphometric feature classification with application to lupus. Front Hum Neurosci 2010;4:27

    PubMed